This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Deregulation of the mRNA translational process has been observed during tumorigenesis. However, recent findings have shown that deregulation of translation also contributes specifically to cancer cell spread. During metastasis, cancer cells undergo changes in cellular state, permitting the acquisition of features necessary for cell survival, dissemination, and outgrowth. In addition, metastatic cells respond to external cues, allowing for their persistence under significant cellular and microenvironmental stresses. Recent work has revealed the importance of mRNA translation to these dynamic changes, including regulation of cell states through epithelial-to-mesenchymal transition and tumor dormancy and as a response to external stresses such as hypoxia and immune surveillance. In this review, we focus on examples of altered translation underlying these phenotypic changes and responses to external cues and explore how they contribute to metastatic progression. We also highlight the therapeutic opportunities presented by aberrant mRNA translation, suggesting novel ways to target metastatic tumor cells.
Footnotes
Cancer Res 2021;81:517–24
- Received August 9, 2020.
- Revision received September 25, 2020.
- Accepted October 23, 2020.
- Published first January 21, 2021.
- ©2021 American Association for Cancer Research.
Log in using your username and password
Purchase access
Volume 81, Issue 3
